Header menu link for other important links
X
Regulation of Monoamine Oxidase B Gene Expression: Key Roles for Transcription Factors Sp1, Egr1 and CREB, and microRNAs miR-300 and miR-1224
Published in Academic Press
2019
PMID: 30738894
Volume: 431
   
Issue: 6
Pages: 1127 - 1147
Abstract
Monoamine oxidase B (MAO-B), a flavoenzyme located in the outer mitochondrial membrane, is involved in the catabolism of monoamines. Altered levels of MAO-B are associated with cardiovascular/neuronal diseases. However, molecular mechanisms of MAO-B gene regulation are partially understood. We undertook a systematic analysis of the MAO-B gene to identify the key transcriptional/post-transcriptional regulatory molecules. Expression of MAO-B promoter–reporter constructs in cultured cells identified the − 144/+25-bp domain as the core promoter region. Stringent in silico analysis of this core promoter predicted binding sites for several transcription factors. Over-expression/down-regulation of transcription factors Sp1/Egr1/CREB increased/decreased the MAO-B promoter–reporter activity and endogenous MAO-B protein level. Electrophoretic mobility shift assays and ChIP assays provided evidence for interactions of Sp1/Egr1/CREB with the MAO-B promoter. MAOB transcript level also positively correlated with the transcript level of Sp1/Egr1/CREB in various human tissue samples. Computational predictions using multiple algorithms coupled with systematic functional analysis revealed direct interactions of the microRNAs miR-1224 and miR-300 with MAO-B 3′-UTR. Dopamine dose-dependently enhanced MAO-B transcript and protein levels via increased binding of CREB to MAO-B promoter and reduced miR-1224/miR-300 levels. 8-Bromo-cAMP and forskolin augmented MAO-B expression, whereas inhibition of PKA diminished the gene expression suggesting involvement of cAMP-PKA axis. Interestingly, Sp1/Egr1/CREB/miR-1224 levels correlate with MAO-B expression in rodent models of hypertension/MPTP-induced neurodegeneration, indicating their roles in governing MAO-B gene expression in these disease states. Taken together, this study elucidates the previously unknown roles of the transcription factors Sp1/Egr1/CREB and microRNAs miR-1224/miR-300 in regulating MAO-B gene expression under basal/disease states involving dysregulated catecholamine levels. © 2019 Elsevier Ltd
About the journal
JournalJournal of Molecular Biology
PublisherAcademic Press
ISSN00222836
Open AccessNo
Concepts (37)
  •  related image
    1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE
  •  related image
    AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B
  •  related image
    CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN
  •  related image
    Dopamine
  •  related image
    EARLY GROWTH RESPONSE FACTOR 1
  •  related image
    Microrna
  •  related image
    MICRORNA 1224
  •  related image
    MICRORNA 300
  •  related image
    TRANSCRIPTION FACTOR SP1
  •  related image
    Unclassified drug
  •  related image
    3' UNTRANSLATED REGION
  •  related image
    AGS CELL LINE
  •  related image
    AML12 CELL LINE
  •  related image
    Animal experiment
  •  related image
    Animal model
  •  related image
    Animal tissue
  •  related image
    Article
  •  related image
    Binding site
  •  related image
    Cho cell line
  •  related image
    Controlled study
  •  related image
    Down regulation
  •  related image
    ESSENTIAL HYPERTENSION
  •  related image
    Gene expression regulation
  •  related image
    Hek293 cell line
  •  related image
    Human
  •  related image
    Human cell
  •  related image
    Human tissue
  •  related image
    IMR-32 CELL LINE
  •  related image
    In vitro study
  •  related image
    Male
  •  related image
    Mouse
  •  related image
    Nerve degeneration
  •  related image
    NEURO-2A CELL LINE
  •  related image
    Nonhuman
  •  related image
    Priority journal
  •  related image
    Promoter region
  •  related image
    Rat